A class of common HIV medications has been linked to bone density and kidney problems, and patients claim that the drugmaker has the ability to release a safer drug.
The HIV drugs that come with these bone density and kidney side effects are made by drugmaker Gilead with the active ingredient tenofovir disoproxil fumarate (TDF). The HIV medications at issue include:
- Atripla
- Complera
- Stribild
- Truvada
- Viread
These drugs allegedly lead to chronic kidney disease, including kidney damage and kidney failure, and bone demineralization due to compromised bone density, which in some cases has reportedly led to bone fractures.
If you take one of the HIV medications listed above and suffered from kidney or bone density problems, you may qualify to join this HIV drug lawsuit investigation.
Learn more by filling out the form on this page for a free case evaluation.
Overview: HIV Medications Side Effects
The drugmaker Gilead makes several HIV drugs that contain the active ingredient tenofovir that are antiretroviral medications in a class called nucleoside reverse transcriptase inhibitors (NRTIs).
These drugs are supposed to prevent the HIV virus from replicating in the bodies of those who have the disease. Stopping replication from happening is important because it prevents the transmission of the disease and it helps the immune system.
HIV drugs that contain the active ingredient tenofovir made by Gilead include:
- Atripla
- Complera
- Stribild
- Truvada
- Viread
Atripla, Truvada, Viread Lawsuits & Class Action Lawsuits
Personal injury lawsuits and class action lawsuits have been filed against drugmaker Gilead alleging that its tenofovir containing drugs such as Atripla, Truvada and Viread cause toxicity to kidneys and bones.
A Truvada lawsuit filed in July 2018 says that the problem is that these drugs have low bioavailability, which means that it’s not absorbed very well. As a result, the HIV drugs need to be “ingested at high doses in order to provide the promised antiviral effect.”
The excessive amount of tenofovir ends up in patients’ bones and kidneys, the Truvada lawsuit says. And this is happening to patients who are already taxed with having to fight the HIV infection.
The Truvada lawsuit alleges that Gilead was aware of these issues from the time that the drug was developed, specifically that the drug had low bioavailability and that the kidneys and bones were impacted by high doses.
Gilead allegedly downplayed these HIV medication side effects by only suggesting that “doctors ‘consider monitoring’ bone mineral density ‘in patients with a history of pathologic fracture or who are at risk for osteopenia.’”
The man who filed the Truvada lawsuit in July was only 26 years old when he began taking the HIV drug and did not have a history of osteopenia or fractures, but he alleges that Truvada compromised his bone mineral density.
The Truvada lawsuit also alleges that Gilead has a safer drug that exposes the kidneys and bones to a much lower level of toxicity that the drugmaker has withheld from the public “until Gilead had exhausted the profits it could earn from Truvada.”
Gilead has also faced similar allegations concerning Atripla, Complera, Stribild, and Viread.
HIV Medications Lawsuit Investigation
Drugs such as Atripla, Complera, Stribild, Truvada, Viread have been linked to the following side effects:
- Bone mineral density loss
- Bone necrosis (bone death)
- Bone fracture
- Osteopenia
- Osteoporosis
- Kidney toxicity
- Chronic kidney disease
- Kidney damage
- Kidney failure
If you or a loved one has suffered from one of the side effects listed above while taking an HIV drug containing tenofovir, you may qualify for this HIV medications lawsuit investigation.
An HIV drug side effects lawsuit can help to recover damages for medical bills, lost wages, and pain and suffering.
Learn more by filling out the free form on this page.
GET HELP – IT’S FREE
Join a Free HIV Medications Lawsuit Investigation
If you qualify, an attorney will contact you to discuss the details of your potential case at no charge to you.
PLEASE NOTE: If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client or getting you dropped as a client.
ATTORNEY ADVERTISING
The choice of a lawyer is an important decision and should not be based solely on advertisements.
Counsel responsible for this advertisement include Steven D. Gacovino at Gacovino Lake & Associates PC
PAID ATTORNEY ADVERTISEMENT: THIS WEB PAGE IS AN ADVERTISEMENT AND THE PARTICIPATING ATTORNEY(S) ARE INCLUDED BECAUSE THEY PAY AN ADVERTISING FEE. Top Class Actions is not a law firm, lawyer referral service, or prepaid legal services plan. We do not endorse or recommend any third-party claims processing company, lawyer, or law firm who participates in the network. We do not make any representation and have not made any judgment, as to the qualifications, expertise, or credentials of any participating lawyer or processing group. No representation is made that the quality of the legal services or claims processing to be performed is greater than the quality of legal services or claims processing performed by other lawyers or claims processing group. The information contained herein is not legal advice. Any information you submit to Top Class Actions does not create an attorney-client relationship and might not be protected by attorney-client privilege. Instead, your information will be forwarded to an attorney or claims processing firm for the purpose of a confidential review and potential representation. You should not use this website to submit confidential, time-sensitive, or privileged information. All photos contained on this website are of models and do not depict clients.
